Obesity management has changed significantly over the past several decades. Today, several medications are approved by the U.S. Food and Drug Administration (FDA) for long-term weight management. These medications are generally prescribed alongside lifestyle modifications to help manage overweight and obesity as chronic health conditions.
Medical guidelines generally recommend considering weight loss medication for adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher when certain weight-related health conditions are present. Eligibility depends on individual circumstances, medical history, and local prescribing guidelines. In this article, we’ll take a closer look at weight loss medication and its role in addressing obesity.
Table of Contents
The Role of Weight Loss Medication
Lifestyle modifications, including balanced nutrition, regular physical activity, sufficient sleep, and behavioral support, are important parts of obesity management. However, lifestyle changes alone may not lead to the desired results for everyone. Weight loss medications can complement these efforts, particularly for individuals whose weight is influenced by biological, genetic, environmental, or medical factors.
For a broader overview of available approaches, read our guide to different methods to lose weight.
Weight loss medications work through different mechanisms. Some influence appetite-regulating hormones and brain signals to increase feelings of fullness and reduce hunger. Others may reduce the absorption of dietary fat or affect the central nervous system to support appetite control. The effects, benefits, and potential risks vary by medication.
Types and Brands of Weight Loss Medication
Obesity medications include several drug classes. Two important groups are GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists.
GLP-1 Receptor Agonists
GLP-1 (glucagon-like peptide-1) receptor agonists act on pathways involved in appetite regulation, fullness, and blood glucose control. Two well-known medications in this category are Saxenda and Wegovy.
Saxenda contains liraglutide and is administered as a daily injection. Wegovy contains semaglutide and is generally administered as a weekly injection. Both can help reduce appetite and support weight management when used alongside appropriate lifestyle changes, although their dosing schedules, approved uses, and results differ.
The choice between medications depends on several factors, including medical history, other health conditions, potential side effects, cost, insurance coverage, availability, and patient preference. A healthcare provider can help determine which treatment, if any, is appropriate.
Dual GIP/GLP-1 Receptor Agonists
Tirzepatide acts on both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. It was initially approved under the brand name Mounjaro for type 2 diabetes in the United States. A tirzepatide product, Zepbound, subsequently received FDA approval for chronic weight management in eligible adults.
Tirzepatide is administered as a weekly injection, with the dose increased gradually according to the prescribing instructions and the individual’s response. Treatment typically begins at a low dose to help the body adjust, and the appropriate maintenance dose is determined by a healthcare provider.
Clinical trials have demonstrated substantial average weight loss with tirzepatide in some participants. However, individual results vary, and the medication is not suitable for everyone. It should be used under medical supervision, with attention to potential side effects and contraindications.
Rules and Safety
Eligibility for weight loss medication should be determined in consultation with a qualified healthcare provider. A thorough assessment of an individual’s medical history, current health, other medications, weight-related conditions, and potential contraindications helps guide treatment decisions.
Weight loss medications can support appetite control, reduce hunger, and increase feelings of fullness, but they are not a replacement for a comprehensive approach to health. Treatment effectiveness varies, and possible side effects should be discussed before starting medication. Patients should follow their prescribed dosing schedule and avoid changing or stopping treatment without consulting their healthcare provider.
Lifestyle support can also be valuable. A structured plan may include balanced dietary choices, regular physical activity, behavioral strategies, adequate sleep, and realistic goals. For some people, approaches such as intermittent fasting for women may be worth discussing with a healthcare professional, although fasting is not appropriate for everyone and is not required for successful weight management.
A coach or registered dietitian may help individuals develop practical habits and stay accountable, but coaching should complement—not replace—medical care when prescription medication is involved. Any dietary or exercise plan should be adapted to the person’s health, preferences, and treatment needs.
It is also important to distinguish evidence-based medical treatment from celebrity weight-loss stories. For example, our article about John Cena’s weight loss journey offers a different perspective on weight-related goals, but a public figure’s experience should not be treated as a medical plan or a guarantee of similar results.
Conclusion
Understanding the different types of weight loss medication, their potential benefits, and their safety considerations is essential for people exploring obesity treatment. These medications can be useful tools for eligible individuals, especially when combined with sustainable lifestyle changes and appropriate medical follow-up.
The best treatment plan is personalized. By working with a qualified healthcare provider, individuals can weigh the potential benefits and risks, set realistic expectations, and pursue a safer, more sustainable approach to long-term weight management.
